Skip to content

Medical-device intelligence

SBH: Integrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter

FDA product code SBH: Integrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
SBH
FDA device name
Integrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter
Device class
2
Regulation number
862.1355
Medical specialty
Clinical Chemistry
Review panel
CH

FDA definition

An integrated continuous glucose monitoring system (iCGM) for non-intensive glucose management is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time to detect euglycemic and dysglycemic glucose levels across the range spanning clinically significant hypoglycemia and hyperglycemia levels in persons who are not on insulin and who do not have a significant risk of problematic hypoglycemia. iCGM systems for non-intensive glucose management are designed to reliably and securely transmit glucose measurement data to digitally connected devices, excluding devices intended to control the delivery of insulin, and are intended to be used alone or in conjunction with these digitally connected medical devices.
Explore clinical chemistry records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

3 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Jun 7, 2024 to Aug 11, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202610
July 202600
August 202610
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

3 matching records
Device / recordCompany in FDA recordSourceSource date
Stelo Glucose Biosensor SystemK262472 · SBHDexcom, Inc.510(k)Aug 11, 2026FDA decision date
Stelo Glucose Biosensor SystemK260935 · SBHDexcom, Inc.510(k)Jun 12, 2026FDA decision date
Libre Rio Continuous Glucose Monitoring SystemK233861 · SBHAbbott Diabetes Care510(k)Jun 7, 2024FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗